Federal Register #2026-18200

DEA Revokes Registration of Stephen Bossenberry, M.D. for Controlled Substances in Michigan

This notice announces the DEA's revocation of Stephen Bossenberry, M.D.'s registration for handling controlled substances in Michigan. - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - OEMs and Vendors: - DEA (issuing authority) - Products/Services Requested: - No products or services are being requested or procured - Unique or Notable Requirements: - Revocation is based on lack of state authority to handle controlled substances - All pending applications for renewal, modification, or additional registration are denied - Administrative action, not a procurement opportunity

Description

This notice pertains to the decision and order regarding Stephen Bossenberry, M.D., issued by the Drug Enforcement Administration under the Department of Justice. The order revokes the DEA Certificate of Registration No. FB7239393 for Stephen Bossenberry, M.D., due to his lack of authority to handle controlled substances in Michigan, where he is registered. The revocation is effective October 8, 2026, and any pending applications for renewal or modification of his registration are denied. The document is published in the Federal Register, volume 91, pages 57163-57164, on September 8, 2026.

View original listing